CASI - CASI Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5331.18M
Enterprise Value 3284.73M
Trailing P/E N/A
Forward P/E 1-15.04
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.72
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-8.45

Trading Information

Stock Price History

Beta (3Y Monthly) 1.05
52-Week Change 3-35.88%
S&P500 52-Week Change 34.18%
52 Week High 36.2300
52 Week Low 32.7300
50-Day Moving Average 33.2106
200-Day Moving Average 33.1950

Share Statistics

Avg Vol (3 month) 3191.41k
Avg Vol (10 day) 3474.58k
Shares Outstanding 595.72M
Float 35.1M
% Held by Insiders 141.36%
% Held by Institutions 121.00%
Shares Short (Aug 15, 2019) 44.33M
Short Ratio (Aug 15, 2019) 428.81
Short % of Float (Aug 15, 2019) 48.67%
Short % of Shares Outstanding (Aug 15, 2019) 44.53%
Shares Short (prior month Jul 15, 2019) 44.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 211/1
Last Split Date 3Jul 1, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-21.98%
Return on Equity (ttm)-42.98%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -33.69M
Net Income Avi to Common (ttm)-41.43M
Diluted EPS (ttm)-0.4440
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)70.97M
Total Cash Per Share (mrq)0.74
Total Debt (mrq)4.28M
Total Debt/Equity (mrq)3.92
Current Ratio (mrq)13.04
Book Value Per Share (mrq)0.93

Cash Flow Statement

Operating Cash Flow (ttm)-32.92M
Levered Free Cash Flow (ttm)-28.95M